According to NeoGenomics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.44. At the end of 2024 the company had a P/S ratio of 3.27.
Year | P/S ratio | Change |
---|---|---|
2024 | 3.27 | -6.18% |
2023 | 3.49 | 52.25% |
2022 | 2.29 | -73.6% |
2021 | 8.67 | -35.51% |
2020 | 13.5 | 79.41% |
2019 | 7.50 | 74.16% |
2018 | 4.30 | 49.01% |
2017 | 2.89 | 4.79% |
2016 | 2.76 | -53.89% |
2015 | 5.98 | 107.23% |
2014 | 2.89 | 7.85% |
2013 | 2.68 | 42.62% |
2012 | 1.88 | 34.75% |
2011 | 1.39 | -1.66% |
2010 | 1.42 | -25.21% |
2009 | 1.89 | 95.83% |
2008 | 0.9665 | -67.2% |
2007 | 2.95 | -52.99% |
2006 | 6.27 | 172.35% |
2005 | 2.30 | -76.15% |
2004 | 9.65 | 286.99% |
2003 | 2.49 | -93.43% |
2002 | 37.9 | -97.27% |
2001 | > 1000 |